[Common recommendation of specialty representatives for social medicine of German medical faculties].

B. Robra,H. Woitowitz

Das Gesundheitswesen

Abstract:

What problem does this paper attempt to address?

Clonidine patch: reservoir for abuse.

C. Fetrow,J. Hoyt,T. White

Abstract:
Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report

Haruka Toyonaga,Masashi Fukushima,Naoto Shimeno,Tetsuro Inokuma

DOI: https://doi.org/10.1186/s12876-019-0982-4

2019-04-25

Abstract:Background: Methotrexate-associated lymphoproliferative disorder (MTX-LPD) can present as a benign lymphoid proliferation or a malignant lymphoma in patients taking MTX. Almost 50% of MTX-LPD cases show spontaneous remission after withdrawal of MTX treatment. Studies have suggested that the hyper-immune state of rheumatoid arthritis, the immunosuppressive state associated with MTX, and the carcinogenicity of the Epstein-Barr virus might contribute to MTX-LPD development. Although most cases of MTX-LPD occur at extranodal sites, few cases of MTX-LPD affecting the stomach and duodenum have been reported. To our knowledge, no other study has reported on the endoscopic observations of dramatic withdrawal and appearance of multiple digestive tract lesions in a short period of time. Herein, we report the clinical course and imaging findings of our case, which may be useful for understanding the pathological condition of MTX-LPD. Case presentation: We describe the case of a 70-year-old woman with MTX-LPD of the stomach and duodenum. Disease regression was temporarily achieved after cessation of MTX treatment; however, it subsequently recurred, and complete response was only achieved after six cycles of rituximab, cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisolone (R-CHOP) chemotherapy. Conclusions: The first-choice therapy for patients taking MTX who develop suspected MTX-LPD should be the withdrawal of MTX treatment. Even after remission is achieved, patients should be kept under careful observation, and if the disease recurs, chemotherapy should be commenced promptly.
Pulmonary Intravascular Large B-cell Lymphoma in a Patient Administered Methotrexate for Rheumatoid Arthritis

Eri Iwami,Fumimaro Ito,Kotaro Sasahara,Aoi Kuroda,Tatsu Matsuzaki,Takahiro Nakajima,Daichi Abe,Kimihiro Matsumoto,Aya Sasaki,Keisuke Eguchi,Takeshi Terashima

DOI: https://doi.org/10.2169/internalmedicine.3216-19

2020-02-01

Internal Medicine

Abstract:A 70-year-old woman with rheumatoid arthritis undergoing methotrexate (MTX) treatment presented with dyspnea and a subfever. Computed tomography (CT) revealed a diffuse minimal ground-glass appearance in both lungs and splenomegaly. The gallium scintigram showed a diffuse, mild uptake in both lungs and the spleen. The lung biopsy specimen revealed the presence of CD20-positive atypical lymphocytes in the small pulmonary vessels. The patient was diagnosed with pulmonary intravascular diffuse large B-cell lymphoma (IVLBCL) and exhibited spontaneous regression after MTX was discontinued. This report describes a rare case of MTX-associated lymphoproliferative disorder expressing pulmonary IVLBCL.

medicine, general & internal
Multiple Ulcers in the Ileum and Lymphadenopathy Following the Usage of Methotrexate in a Patient With Rheumatoid Arthritis: A Case Report

Ryuichi Ohta,Tsuyoshi Mishiro,Yuta Horinishi,Chiaki Sano

DOI: https://doi.org/10.7759/cureus.53406

2024-02-01

Cureus

Abstract:This case report aims to highlight a rare occurrence of severe anemia and lymphadenopathy secondary to methotrexate (MTX)-induced ileal mucosa damage in a patient with elderly onset rheumatoid arthritis (EORA). We present the case of a 72-year-old female with a history of EORA, treated with MTX, who exhibited hematochezia without accompanying pain, diarrhea, or known infectious contacts. Diagnostic investigations included imaging and endoscopic procedures. The patient's presentation of severe anemia was atypical, given the absence of significant pain or discomfort associated with EORA. The lack of active bleeding observed during endoscopy, coupled with multiple ileal ulcers, suggested a chronic progression of mucosal damage. Laboratory findings, including normal lactate dehydrogenase, soluble interleukin-2 receptor levels, and the absence of malignancy in mucosal biopsies, ruled out MTX-induced lymphoma. The patient's condition improved with the cessation of MTX and the introduction of symptomatic treatment and anemia management. This case underscores the need for vigilant monitoring and comprehensive evaluation in patients with RA, especially the elderly, treated with MTX. It also highlights the importance of considering drug-induced complications in the differential diagnosis of anemia. The case demonstrates the necessity of a personalized approach to treatment, emphasizing regular follow-ups and adjustments based on the patient's response to therapy. This report contributes to the growing body of evidence on the complexities of managing RA in the elderly, particularly regarding the side effects of common medications like MTX.
Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case

Masao Hagihara,Toru Mese,Shin Ohara,Jian Hua,Shiro Ide,Morihiro Inoue

DOI: https://doi.org/10.2169/internalmedicine.0875-18

2018-10-15

Internal Medicine

Abstract:We herein report a rare case of methotrexate (MTX)-associated intravascular large B-cell lymphoma (IVLBCL) in a man with rheumatoid arthritis. Two episodes of a fever of unknown origin accompanied by elevated levels of serum lactate dehydrogenase and the soluble interleukin-2 receptor occurred within a year, so the patient was suspected of having an MTX-associated lymphoproliferative disorder. His clinical symptoms resolved after the cessation of MTX. However, after treatment with iguratimod, another disease-modified anti-rheumatic drug, markedly similar symptoms recurred, and random skin biopsies resulted in a diagnosis of IVLBCL. The patient received a rituximab-containing chemotherapy and achieved complete remission.

medicine, general & internal
Changes in Hypothalamic and Pituitary Content of Immunoreactive α-Melanocyte-Stimulating Hormone during the Gestational and Postpartum Periods in the Rat 1

O. Khorram,L. Depalatis,S. Mccann

DOI: https://doi.org/10.3181/00379727-177-41950

1984-11-01

Abstract:Abstract α-Melanocyte-stimulating hormone (α-MSH) was measured in the mediobasal hypothalamus (MH), median eminence (ME), preoptic-suprachiasmatic area (POA–SCN), anterior (AL), and posterior lobes (PL) of the pituitary gland during the gestational and postpartum periods in the rat. The content of α-MSH in the MH and POA–SCN compared to estrous levels was lower during the later days of gestation and decreased further in the MH during lactation in association with the elevated plasma prolactin (Prl). Distinct increases in the ME content of α-MSH compared to estrous levels occurred on Days 8 and 12 of the gestational period and Day 14 of the postpartum period. A significant increase in PL content of α-MSH compared to Days 5–11 and 17–20 occurred on Day 4 of gestation, and no significant changes were detected in the AP concentration of α-MSH throughout the period studied. In vitro, PLs and ALs from females on Day 4 of gestation secreted more α-MSH into the incubation medium than tissues from animals on Day 20. These results suggest that α-MSH of both brain and pituitary origin may play a role in mediating some of the physiological changes which occur during pregnancy and lactation.
Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate

Elizabeth H Quaye,Christopher D'Angelis,Jennifer Powell

DOI: https://doi.org/10.5070/D329160212

2023-02-15

Abstract:Methotrexate (MTX) is a first-line systemic medication used to treat rheumatoid arthritis because of its immunomodulatory effects. However, MTX has also been linked to the development of lymphoproliferative disorders (LPD) in patients with rheumatoid arthritis. We describe a patient with long-standing rheumatoid arthritis treated with MTX who developed cutaneous Epstein-Barr virus (EBV)-positive B cell lymphoproliferative disease resembling grade III lymphomatoid granulomatosis localized to the right leg. The lymphomatoid process resolved with withdrawal of the MTX. The pathogenesis of iatrogenic lymphoproliferative disorder was most likely triggered by the rheumatoid inflammation and the immunosuppressing effects of MTX, which led to EBV reactivation. We recommend a trial of MTX discontinuation prior to considering chemotherapy in patients with rheumatoid arthritis treated with MTX who develop EBV-positive B cell lymphoproliferative disease resembling a high grade B-cell lymphoma.
Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature

Ayumi Ogawa,Tsuyoshi Nakagawa,Yuichi Kumaki,Tokuko Hosoya,Goshi Oda,Mio Mori,Tomoyuki Fujioka,Kazunori Kubota,Iichiro Onishi,Hiroyuki Uetake

DOI: https://doi.org/10.1186/s13256-022-03274-1

2022-02-07

Abstract:Background: Lymphoproliferative disorder (LPD) has been shown to occur after treatment with methotrexate (MTX). Currently, MTX-LPD has become widely recognized, but its mechanism and prognostic factors remain unclear. Case presentation: We report the first case of Epstein-Barr virus (EBV)-associated MTX-LPD of the breast. A 63-year-old Asian woman with long-term rheumatoid arthritis presented to our facility with intermittent fever. A physical examination revealed a 3-cm lump in her left breast. She had been taking MTX for the past 15 years. Laboratory studies revealed slightly elevated levels of EBV-viral capsid antigen antibody immunoglobulin G and EBV nuclear antibody. Contrast-enhanced computer tomography revealed a mass in the left breast, a subcutaneous nodule in the abdomen, a mass in the left lung, and a nodule in the left retroperitoneum. The definitive diagnosis was consistent with MTX-LPD merging into an EBV-positive, diffuse large B-cell lymphoma. Six months following the withdrawal of MTX, the breast mass had markedly shrunk and the patient remained in good health for 1 year with no evidence of relapse of LPD. Conclusion: MTX-LPD rarely occurs in the breast, and it is difficult to diagnose because there have only been six reported cases of breast MTX-LPD reported in the literature. EBV-positive MTX-LPD tends to regress spontaneously after MTX withdrawal, and our case also had similar results. It is important to make an appropriate diagnosis of MTX-LPD of the breast based on imaging and pathology to determine the appropriate treatment protocol for this rare disorder.
Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin‐associated large B‐cell lymphoma‐like lesions in aortic and mitral valves

Hideaki Tsujii,Ryuko Nakayama,Sohei Funakoshi,Shuhei Tsuji,Hironori Haga,Kazuo Ono

DOI: https://doi.org/10.1111/pin.13424

2024-04-03

Pathology International

Abstract:We herein report a case of methotrexate‐associated lymphoproliferative disorder (MTX‐LPD) showing fibrin‐associated large B‐cell lymphoma‐like heart valve lesions, and Epstein‐Barr virus (EBV)‐positive mucocutaneous ulcer‐like cutaneous and oral mucosal lesions. MTX‐LPD is a critical complication that can occur in RA patients who are treated with MTX. EBV also plays a defining or important role in LPDs. Among the sites of MTX‐LPD, 40−50% occur in extranodal sites, including the gastrointestinal tract, skin, liver, lung, and kidney. There are few reports of MTX‐LPDs involving the heart valves, and to the best of our knowledge, this is the first case to be reported in the English literature. The possibility of EBV‐positive LPD should be considered in RA patients, even in patients with an atypical site, as in this case.

pathology
Hemophagocytic Syndrome-Associated Variant of Methotrexate-Associated Intravascular Large B-Cell Lymphoma in a Rheumatoid Arthritis Patient

Yukiko Komeno,Minako Akiyama,Yasumi Okochi,Hitoshi Tokuda,Keiko Abe,Kuniko Iihara,Tomiko Ryu

DOI: https://doi.org/10.1155/2019/8947616

2019-09-11

Case Reports in Hematology

Abstract:A 59-year-old man was treated for rheumatoid arthritis (RA) for 12 years with methotrexate (MTX) and prednisolone. After MTX-associated interstitial pneumonia developed, he was treated with cyclophosphamide and prednisolone for 7 months. Arthritis worsened, and tacrolimus was added to the treatment regimen. One month later, he had fever, loss of appetite, and dyspnea on exertion. Blood tests showed pancytopenia with large, atypical lymphocytes. Computed tomography showed mild splenomegaly. Bone marrow examination demonstrated CD20-positive, EBER-positive atypical lymphocytes, and hemophagocytosis. Random skin biopsy led to the diagnosis of intravascular large B-cell lymphoma (IVLBCL). The final diagnosis was a hemophagocytic syndrome-associated variant of IVLBCL. Complete remission was achieved after seven courses of R-CHOP. However, within a month, he complained of dizziness. Magnetic resonance imaging revealed focal infarctions in the cerebellum and around the left lateral ventricle. Central nervous system relapse was suspected. Although salvage chemotherapy (CHASER), whole brain irradiation, and intrathecal injection of cytarabine and prednisolone were temporarily effective, he died. Autopsy revealed infiltration of lymphoma cells in the brain and adrenal glands. To the best of our knowledge, this is the sixth case of IVLBCL and the first case of the hemophagocytic syndrome-associated variant of IVLBCL in RA patients in the literature.
Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis

Ichiro Takajo,Kunihiko Umekita,Yoshihiko Ikei,Koichi Oshima,Akihiko Okayama

DOI: https://doi.org/10.2169/internalmedicine.0308-17

2018-07-15

Internal Medicine

Abstract:The patient was a 74-year-old Japanese woman with rheumatoid arthritis (RA) who developed generalized lymphadenopathy with elevated levels of lactase dehydrogenase (LD), and soluble IL-2 receptor (sIL-2R). She was found to be positive for anti-human T-cell leukemia virus type 1 (HTLV-1) antibodies. Her symptoms and laboratory abnormalities spontaneously regressed after the cessation of methotrexate (MTX), suggesting that she had an MTX-associated lymphoproliferative disorder; however, her lymphadenopathy appeared again approximately 14 months later with LD and sIL-2R elevation. A histopathological analysis and Southern blotting of a lymph node biopsy specimen for HTLV-1 provirus supported the diagnosis of adult T-cell leukemia/lymphoma (ATL) (lymphoma type). These data confirmed that an HTLV-1 positive RA patient may develop ATL.

medicine, general & internal
Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.

G. Gulli,L. Rossetti,R. DeFronzo

DOI: https://doi.org/10.1016/S0026-0495(97)90209-2

1997-10-01

Abstract:
[Histological and histochemical studies on the effect of dimethyl sulfoxide (DMSO) on guinea pig skin].

F. Vakilzadeh

Abstract:
Why and how do women recover from bulimia nervosa? The subjective appraisals of forty women recovered for a year or more.

M. Rorty,J. Yager,E. Rossotto

DOI: https://doi.org/10.1002/1098-108X(199311)14:3<249::AID-EAT2260140303>3.0.CO;2-O

1993-11-01

International Journal of Eating Disorders

Abstract:As part of a larger study of recovery in bulimia nervosa, 40 women recruited by local advertisement and referral who were recovered from the disorder for a year or more (median recovery = 36 months) participated in semistructured interviews regarding factors they believed to be related to their recovery process. We asked how life experiences and important persons in their lives had helped or hindered their recovery, what aspects of bulimia nervosa they found hardest to change and what they would still like to change, what they felt they gave up by recovering, and their beliefs about the potential for full, lasting recovery. We further inquired about professional and nonprofessional treatments utilized, our subjects' satisfaction with care, and specific helpful and harmful elements in treatment. Spontaneous answers were coded from audiotaped interviews. The women reported diverse experiences, many of which were consistent with clinical and empirical accounts. Almost 90% had received some treatment by a mental health professional, and many also had utilized nonprofessional treatments, particularly Overeaters Anonymous; these treatments were described as helpful by the majority using them. Of note, although parents often provided some practical support for treatment, the majority of subjects reported that their mothers and fathers were more harmful than helpful in the recovery process.
Pulmonary Non-Hodgkin’s Lymphoma Developed During Long-Term Methotrexate Therapy for Rheumatoid Arthritis

Huiying Wang,Dandan Wu,Hua Xiang,Aifeng Chen,Jin Liu

DOI: https://doi.org/10.1007/s00296-010-1496-0

2010-01-01

Rheumatology International

Abstract:Methotrexate is effective in treating rheumatoid arthritis (RA). Some reports have discussed the possible association between methotrexate and lymphoma. Here, we report a case of pulmonary non-Hodgkin’s lymphoma (NHL) developed after 11 years’ methotrexate therapy for RA. Biopsy of the pulmonary mass demonstrated a diffuse large B-cell lymphoma. After withdrawal of methotrexate without any other intervention for 4 weeks, a significant reduction in the size of the lymphoma was observed. The causative relationship between methotrexate and pulmonary lymphoma is suggested by the persistent remission after stopping methotrexate therapy.
Methotrexate-associated lymphoproliferative disorder: A rare pancreatic tumor diagnosed via endoscopic ultrasound-guided fine-needle biopsy

Koh Kitagawa,Masafumi Oyama,Shohei Asada,Shinya Sato,Tatsuya Nakatani,Naoki Nishimura,Yuka Mui,Jun-Ichi Hanatani,Maiko Takeda,Hitoshi Yoshiji

DOI: https://doi.org/10.1002/deo2.346

2024-03-05

DEN Open

Abstract:A 73-year-old woman with a history of rheumatoid arthritis treated with methotrexate (MTX) for the last 10 years was referred to our hospital for a pancreatic tumor examination. Contrast-enhanced abdominal computed tomography revealed a 20-mm-diameter hypovascular tumor in the pancreatic tail. A hypoechoic mass with heterogeneous internal echo was found on an endoscopic ultrasound (EUS). An EUS-guided fine-needle biopsy (EUS-FNB) was performed with a 22-gauge Franseen-tip needle. Histologic examination of EUS-FNB specimens from the pancreatic tumor revealed the proliferation of atypical spindle cells. Immunohistochemical staining for CD20 and Ki-67 was positive in the atypical cells. Immunohistochemical staining for CD3 was partially positive in the atypical cells. Epstein-Barr virus-encoded RNA in situ hybridization showed positive staining. MTX-related lymphoproliferative disorder (MTX-LPD) with Epstein-Barr virus infection was diagnosed. MTX treatment was immediately discontinued, and treatment was initiated by a hematologist. However, her condition rapidly deteriorated, and she died of multiple organ failure 4 weeks after diagnosis. MTX-LPD can complicate gastrointestinal lesions. However, most lesions are localized in the stomach and rarely complicate pancreatic lesions. MTX-LPD is classified as an "iatrogenic" LPD. Therefore, immediate action, such as MTX discontinuation, is necessary. In conclusion, endoscopists should be aware that MTX-LPD lesions can occur in the pancreas and gastrointestinal tract. Moreover, EUS-FNB can be useful in the diagnosis of this rare pancreatic tumor.
Composite Cutaneous Lymphoma (Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder) in a Patient with Rheumatoid Arthritis Treated with Methotrexate: Staging and Evaluation of Response to Therapy with 18F-FDG PET/CT

William Makis,Anthony Ciarallo,Beatrice Wang,Milene Gonzalez-Verdecia,Stephan Probst

DOI: https://doi.org/10.1007/s13139-016-0463-4

2016-12-19

Nuclear Medicine and Molecular Imaging

Abstract:A 67 year old woman with a 10 year history of rheumatoid arthritis (RA) treated with methotrexate and prednisone, presented with a 2 year history of worsening multiple cutaneous plaques of variable appearance. Two distinct skin lesions were biopsied to reveal a composite cutaneous lymphoma, possibly caused by long term methotrexate therapy. An [18F] fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography/computed tomography (PET/CT) was performed to stage the malignancy, and was later repeated to evaluate response to chemotherapy, which guided subsequent management. We present the PET/CT imaging findings of this very rare iatrogenic (methotrexate induced) immunodeficiency-associated lymphoproliferative disorder.
Ring chromosome 14 syndrome. Report of two cases, including extended evaluation of a previously reported patient and review.

L. Zelante,F. Torricelli,S. Calvano,R. Mingarelli,B. Dallapiccola

Abstract:A case of r(14) chromosome is described and new information is added to a previously reported patient. The r(14) syndrome is reviewed on the basis of 37 known patients. The major features include prenatal and postnatal growth retardation, mental retardation, seizures, microcephaly, and distinct facial dysmorphism, including elongated face, narrow palpebral fissures, epicanthus, and broad nasal bridge. Other characteristic anomalies found only in some patients are retinal anomalies, lymphoedema of hands and feet, and prones to pulmonary infections.
Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases

Hajime Yasuda,Jun Ando,Sayako Yoshida,Yasunori Ota,Norio Komatsu,Miki Ando

DOI: https://doi.org/10.2169/internalmedicine.0130-22

2023-02-15

Abstract:Methotrexate-associated lymphoproliferative disorders (MTX-LPDs) with diffuse large B-cell lymphoma (DLBCL) pathology present with high rates of spontaneous regression after methotrexate (MTX) termination, especially in Epstein-Barr virus-encoded RNA (EBER)-positive cases. DLBCL with adrenal involvement is known for an extremely dismal prognosis. However, the prognosis of adrenal DLBCL in the context of MTX-LPD is unknown. We herein report two EBER-positive adrenal DLBCL MTX-LPD patients who achieved long-term remissions of 22 and 40 months with MTX termination alone. Both patients are doing well with no relapse at the time of reporting. Unlike adrenal DLBCL in general, adrenal involvement may not be a poor prognostic factor when restricted to DLBCL MTX-LPDs.
Pathological Vertebral Fracture Arising From Methotrexate-Associated Lymphoproliferative Disorder in a Patient With Systemic Lupus Erythematosus

Takaki Kitamura,Tomonori Shigemura,Yohei Yamamoto,Yasuaki Murata

DOI: https://doi.org/10.7759/cureus.40079

2023-06-07

Cureus

Abstract:The incidence of lymphoproliferative disorders associated with methotrexate is rising in patients with rheumatoid arthritis. These disorders typically exhibit spontaneous tumor regression upon discontinuation of methotrexate therapy. Spinal lesions associated with these diseases are extremely rare. We present a case of systemic lupus erythematosus in which the patient developed lumbar spine lymphoproliferative disorders secondary to methotrexate therapy, which failed to regress despite discontinuation of the drug, ultimately leading to pathological fracture necessitating posterior spinal fixation. A 60-year-old woman had been diagnosed with systemic lupus erythematosus at the age of 55 years and had been taking prednisolone, hydroxychloroquine, and methotrexate. Throughout the course of her treatment, she experienced recurrent tumefaction and lymph node swelling in various locations. These masses and lymphadenopathy were believed to be potential complications of methotrexate-associated lymphoproliferative disorders, leading to the discontinuation of methotrexate. One month prior to cessation of methotrexate therapy, the patient presented to an orthopedic clinic with lower back pain, and T2-weighted magnetic resonance imaging revealed low signal intensity in the Th10 and L2 vertebrae, initially misdiagnosed as lumbar spinal stenosis. The patient was eventually referred to our department under suspicion of malignant pathology. Computed tomography identified a vertical fracture of the L2 vertebra, which, in conjunction with the imaging results, led to the diagnosis of pathological fracture secondary to methotrexate-associated lymphoproliferative disorder. Following admission to our department, bone biopsy and percutaneous pedicle screw fixation were performed one week later. Pathological examination confirmed the diagnosis of methotrexate-associated lymphoproliferative disorder. Given the possibility of pathological fracture in patients on methotrexate therapy experiencing severe back pain, additional imaging studies should be considered.

[Common recommendation of specialty representatives for social medicine of German medical faculties].

Clonidine patch: reservoir for abuse.

Methotrexate-associated lymphoproliferative disorder in the stomach and duodenum: a case report

Pulmonary Intravascular Large B-cell Lymphoma in a Patient Administered Methotrexate for Rheumatoid Arthritis

Multiple Ulcers in the Ileum and Lymphadenopathy Following the Usage of Methotrexate in a Patient With Rheumatoid Arthritis: A Case Report

Methotrexate-associated Intravascular Large B-cell Lymphoma in a Patient with Rheumatoid Arthritis: A Very Rare Case

Changes in Hypothalamic and Pituitary Content of Immunoreactive α-Melanocyte-Stimulating Hormone during the Gestational and Postpartum Periods in the Rat 1

Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate

Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature

Polymorphic lymphoproliferative disorder arising in a rheumatoid arthritis patient, presenting as fibrin‐associated large B‐cell lymphoma‐like lesions in aortic and mitral valves

Hemophagocytic Syndrome-Associated Variant of Methotrexate-Associated Intravascular Large B-Cell Lymphoma in a Rheumatoid Arthritis Patient

Adult T-cell Leukemia/Lymphoma as a Methotrexate-associated Lymphoproliferative Disorder in a Patient with Rheumatoid Arthritis

Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.

[Histological and histochemical studies on the effect of dimethyl sulfoxide (DMSO) on guinea pig skin].

Why and how do women recover from bulimia nervosa? The subjective appraisals of forty women recovered for a year or more.

Pulmonary Non-Hodgkin’s Lymphoma Developed During Long-Term Methotrexate Therapy for Rheumatoid Arthritis

Methotrexate-associated lymphoproliferative disorder: A rare pancreatic tumor diagnosed via endoscopic ultrasound-guided fine-needle biopsy

Composite Cutaneous Lymphoma (Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorder) in a Patient with Rheumatoid Arthritis Treated with Methotrexate: Staging and Evaluation of Response to Therapy with 18F-FDG PET/CT

Ring chromosome 14 syndrome. Report of two cases, including extended evaluation of a previously reported patient and review.

Diffuse Large B-cell Lymphoma with Adrenal Involvement Presenting as Other Iatrogenic Immunodeficiency-associated Lymphoproliferative Disorders: Sustained Remission with Methotrexate Termination Alone in Two Cases

Pathological Vertebral Fracture Arising From Methotrexate-Associated Lymphoproliferative Disorder in a Patient With Systemic Lupus Erythematosus